Test Price
2,800 AED✅ Home Collection Available
ABCD4 Gene Methylmalonic Aciduria CblJ Type Genetic Test in UAE | 2800 AED | DHA-Licensed Diagnostics
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% diagnostic sensitivity via ISO 9001:2015 accredited NGS processing with orthogonal variant confirmation, delivering clinically actionable results for inherited metabolic disorder diagnosis.
- Premium Logistics: VIP Mobile Phlebotomy & temperature-controlled cold-chain home collection available daily from 8 AM to 11 PM across all seven Emirates with real-time sample custody tracking.
- Post-Test Guidance: Complimentary telephonic clinical interpretation of genetic findings provided by a DHA-licensed Consultant Medical Geneticist to support your referring physician.
- Insurance Verification: Direct billing pre-authorisation confirmed within 60 minutes via WhatsApp +971 54 548 8731 for all major UAE insurers.
Test Overview & Methodology
The ABCD4 Gene Methylmalonic Aciduria CblJ Type Genetic Test is a definitive molecular diagnostic assay that sequences the entire coding region of the ABCD4 gene to identify pathogenic variants responsible for methylmalonic aciduria, CblJ type — a rare autosomal recessive inborn error of intracellular cobalamin (vitamin B12) transport. This test is indicated for patients presenting with metabolic acidosis, failure to thrive, neurological regression, and elevated methylmalonic acid on urinary organic acid analysis, enabling precise genetic confirmation, family cascade screening, and informed clinical management guided by a Consultant Medical Geneticist.
| Parameter | DNA Labs UAE — This Test | Alternative Approach |
|---|---|---|
| Methodology | NGS Full Gene Sequencing with Hybrid-Capture Enrichment & Orthogonal Confirmation | Sanger Sequencing — Single Exon Analysis Only |
| Diagnostic Sensitivity | 99.9% for Coding Variants & Splice-Site Mutations | ~85% Restricted to Known Hotspot Regions |
| Turnaround Time | 3 to 4 Weeks — ISO 9001:2015 Validated | 6 to 8 Weeks — Non-Accredited Facilities |
| Variant Classification | ACMG/AMP 2025 Guidelines with Clinical Correlation | Basic Database Annotation Only |
| Pre-Test Genetic Counselling | Included — Telephonic Pedigree Charting Session | Not Included or Separate Fee |
Physician Insight & Safety Protocols
"ABCD4 gene sequencing provides a precise molecular basis for diagnosing cobalamin trafficking disorders, yet it must always be integrated with the patient's complete metabolic and clinical picture. I advise every referring clinician to correlate next-generation sequencing findings with urinary organic acid profiles, plasma homocysteine levels, and a thorough neurological assessment before initiating any therapeutic plan. A negative result does not exclude all forms of methylmalonic aciduria, and comprehensive genetic counselling remains a cornerstone of responsible diagnostic stewardship."
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Medication Advisory
⚠ Medication Advisory
Do not discontinue prescribed therapy without consulting your treating physician. Results from this genetic test offer diagnostic clarity but must not be used independently to alter ongoing treatment regimens, including hydroxocobalamin supplementation, L-carnitine therapy, or dietary protein restriction protocols. All clinical decisions must be made by your managing doctor based on integrated biochemical, genetic, and clinical data.
Exclusion Criteria & Emergency Red Flags
Exclusion Criteria — Do Not Proceed If:
- Patient has received a blood transfusion within the past 14 days (donor DNA may confound results)
- Active haemolytic anaemia or severe leukopenia precluding safe phlebotomy
- Inability to provide informed consent or absence of a legally authorised representative per UAE Federal Decree-Law No. 4 of 2016 on Medical Liability
- Specimen collected in a non-EDTA tube or haemolysed sample — rejection occurs at laboratory intake
🚨 Emergency Red Flags — Seek Immediate Medical Attention If:
- Acute metabolic decompensation: vomiting, lethargy, tachypnoea, or altered consciousness
- Seizures or acute neurological deterioration in a child with suspected metabolic disorder
- Severe hyperammonaemia (>150 µmol/L) requiring emergency metabolic intervention
- Progressive hypotonia with respiratory distress — do not delay for genetic test results
Patient FAQ & Clinical Guidance
1. What is the ABCD4 gene test and why is it clinically important for suspected methylmalonic aciduria?
The ABCD4 Gene Methylmalonic Aciduria CblJ Type Genetic Test is a definitive molecular diagnostic assay that sequences the entire ABCD4 gene to identify pathogenic mutations causing impaired intracellular cobalamin transport, a rare but treatable metabolic disorder. Clinical confirmation through this test enables precise differentiation from other forms of methylmalonic aciduria, guiding targeted therapy with hydroxocobalamin supplementation and preventing irreversible neurological damage through early metabolic intervention.
2. How does the home collection process work across the UAE and what preparation is required?
Our VIP Mobile Phlebotomy team arrives at your location anywhere across all seven Emirates between 8:00 AM and 11:00 PM with full cold-chain logistics, collecting a 5 mL EDTA whole blood sample after verifying your identity and informed consent documentation. Preparation includes completing a mandatory pre-test genetic counselling session to construct a pedigree chart of family members affected with methylmalonic aciduria CblJ type, and you must not have received a blood transfusion within 14 days prior to collection to preserve sample integrity.
3. What is the turnaround time for results and who provides the interpretation?
Results from the ABCD4 gene sequencing test are available within 3 to 4 weeks from sample receipt. Interpretation is provided by our Consultant Medical Geneticist in collaboration with your referring physician. The service includes a complimentary post-test telephonic consultation to explain the clinical significance of findings and to coordinate next diagnostic or therapeutic steps with your treating specialist. A detailed report is delivered in English, with clinical terminology fully explained for your referring doctor.
4. Will my genetic data be kept private and secure?
Yes. Your genetic information is protected under Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All sequence data is encrypted end-to-end, stored on secure servers within the UAE, and never shared with third parties without your explicit written consent. Our laboratory operates under ISO 9001:2015 accredited protocols governing data confidentiality and handling.
UAE Regulatory & Data Privacy Adherence
This diagnostic service operates in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL), ensuring end-to-end encryption and strict access controls for all genetic information. Additionally, health-data handling adheres to Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields, governing the secure processing of electronic medical records and genomic datasets. Patient safety and informed consent protocols follow Federal Decree-Law No. 4 of 2016 on Medical Liability. Our facility is licensed by the Dubai Health Authority (DHA) under License Number 1143 and operates under ISO 9001:2015 certification, with all laboratory processes validated against current international standards for molecular diagnostics.
Clinical & Logistical Metadata
| Test Name | ABCD4 Gene Methylmalonic Aciduria CblJ Type Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3 to 4 Weeks |
| Sample Type / Matrix | 5 mL EDTA Whole Blood — VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection Available Daily 8 AM – 11 PM |
| Methodology Used | NGS Full Gene Sequencing with Hybrid-Capture Enrichment & Orthogonal Confirmation |
| ICD-10-CM Code | E71.120 |
| LOINC Code | 21656-9 |
| DHA Facility License & Laboratory Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE — DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians